1 |
Kruszka P, Addissie YA, Yarnell CM, et al. Muenke syndrome: an international multicenter natural history study[J]. Am J Med Genet A, 2016, 170A(4): 918-929.
|
2 |
Muenke M, Gripp KW, McDonald-McGinn DM, et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome[J]. Am J Hum Genet, 1997, 60(3): 555-564.
|
3 |
Murali CN, McDonald-McGinn DM, Wenger TL, et al. Muenke syndrome: medical and surgical comorbidities and long-term management[J]. Am J Med Genet A, 2019, 179(8): 1442-1450.
|
4 |
Aravidis C, Konialis CP, Pangalos CG, et al. A familial case of Muenke syndrome. Diverse expressivity of the FGFR3 Pro252Arg mutation: case report and review of the literature[J]. J Matern Fetal Neonatal Med, 2014, 27(14): 1502-1506.
|
5 |
Cunningham ML, Seto ML, Ratisoontorn C, et al. Syndromic craniosynostosis: from history to hydrogen bonds[J]. Orthod Craniofac Res, 2007, 10(2): 67-81.
|
6 |
Iseki S, Wilkie AO, Morriss-Kay GM. Fgfr1 and Fgfr2 have distinct differentiation-and proliferation-related ro-les in the developing mouse skull vault[J]. Development, 1999, 126(24): 5611-5620.
|
7 |
Holmes G, Rothschild G, Roy UB, et al. Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology[J]. Dev Biol, 2009, 328(2): 273-284.
|
8 |
Robin NH, Scott JA, Cohen AR, et al. Nonpenetrance in FGFR3-associated coronal synostosis syndrome[J]. Am J Med Genet, 1998, 80(3): 296-297.
|
9 |
Moko SB, Blandin de Chalain TM. New Zealand Maori family with the pro250arg fibroblast growth factor receptor 3 mutation associated with craniosynostosis[J]. J Craniomaxillofac Surg, 2001, 29(1): 22-24.
|
10 |
Doherty ES, Lacbawan F, Hadley DW, et al. Muenke syndrome (FGFR3-related craniosynostosis): expansion of the phenotype and review of the literature[J]. Am J Med Genet A, 2007, 143A(24): 3204-3215.
|
11 |
Reardon W, Wilkes D, Rutland P, et al. Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis[J]. J Med Genet, 1997, 34(8): 632-636.
|
12 |
Agochukwu NB, Solomon BD, Doherty ES, et al. Palatal and oral manifestations of Muenke syndrome (FGFR-3-related craniosynostosis)[J]. J Craniofac Surg, 2012, 23(3): 664-668.
|
13 |
Anderson PJ, Snell B, Moore MH. Muencke syndrome with cleft lip and palate[J]. J Craniofac Surg, 2013, 24(4): 1484-1485.
|
14 |
Öwall L, Kreiborg S, Dunø M, et al. Phenotypic variability in Muenke syndrome-observations from five Danish families[J]. Clin Dysmorphol, 2020, 29(1): 1-9.
|
15 |
Agochukwu NB, Solomon BD, Gropman AL, et al. Epilepsy in Muenke syndrome: FGFR3-related craniosynostosis[J]. Pediatr Neurol, 2012, 47(5): 355-361.
|
16 |
Alam MK, Alfawzan AA, Abutayyem H, et al. Craniofacial characteristics in Crouzon’s syndrome: a systema-tic review and meta-analysis[J]. Sci Prog, 2023, 106(1): 368504231156297
|
17 |
Adam MP, Feldman J, Mirzaa GM, et al. GeneReviews:1993-2024[M]. Seattle: University of Washington, 1993-2024[2024-12-25]. .
|
18 |
Vogels A, Fryns JP. Pfeiffer syndrome[J]. Orphanet J Rare Dis, 2006, 1: 19.
|
19 |
Adam MP, Feldman J, Mirzaa GM, et al. GeneReviews:1993-2024[M]. Seattle: University of Washington, 1993-2024[2024-12-25]. .
|